Showing results (341-350 of 1,170) with videos related to
Sort By:
Pageof 117
Journal of Virology|January 18, 2013
Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stabilityJayaraju Dheekollu, Horng-Shen Chen, Kenneth M Kaye, et al.The Journal of Biological Chemistry|May 6, 2009
Intrinsic RNA binding by the eukaryotic initiation factor 4F depends on a minimal RNA length but not on the m7G capNicholas M Kaye, Kelly J Emmett, William C Merrick, et al.ESC Heart Failure|September 9, 2020
Identification of physiologic treatment targets with favourable haemodynamic consequences in heart failure with preserved ejection fractionDavid M Kaye, Melissa Byrne, Justin Mariani, et al.Circulation. Cardiovascular Quality and Outcomes|October 17, 2022
Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection FractionJennifer Zhou, Danny Liew, David M Kaye, et al.Expert Review of Vaccines|October 19, 2021
Vaccines against leishmaniasis: using controlled human infection models to accelerate developmentVivak Parkash, Paul M Kaye, Alison M Layton, et al.Journal of Cardiac Failure|September 4, 2012
Hemodynamic determinants of the abnormal cardiopulmonary exercise response in heart failure with preserved left ventricular ejection fractionMicha T Maeder, Bruce R Thompson, Nay Htun, et al.Echocardiography (Mount Kisco, N.Y.)|March 3, 2015
Accuracy of Echocardiographic Cardiac Index Assessment in Subjects with Preserved Left Ventricular Ejection FractionMicha T Maeder, Sofie Karapanagiotidis, Elizabeth M Dewar, et al.Journal of Molecular Biology|November 26, 2002
Conservation of helical structure contributes to functional metal ion interactions in the catalytic domain of ribonuclease P RNANicholas M Kaye, Nathan H Zahler, Eric L Christian, et al.Clinical Pharmacology and Therapeutics|April 1, 1976
Observations on the pharmacokinetics of acebutololC M Kaye, C R Kumana, M Leighton, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathologyS C Smelt, S E Cotterell, C R Engwerda, et al.Pageof 117